The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
Open accessAbstract
The 2023 update of the Chinese Society of Clinical Oncology (CSCO) Clinical Guidelines for Gastric Cancer focuses on standardizing cancer diagnosis and treatment in China, reflecting the latest advancements in evidence‐based medicine, healthcare resource availability, and precision medicine. These updates address the differences in epidemiological characteristics, clinicopathological features, tumor biology, treatment patterns, and drug selections between Eastern and Western gastric cancer patients. Key revisions include a structured template for imaging diagnosis reports, updated standards for molecular marker testing in pathological diagnosis, and an elevated recommendation for neoadjuvant chemotherapy in stage III gastric cancer. For advanced metastatic gastric cancer, the guidelines introduce new recommendations for immunotherapy, anti‐angiogenic therapy and targeted drugs, along with updated management strategies for human epidermal growth factor receptor 2 (HER2)‐positive and deficient DNA mismatch repair (dMMR)/microsatellite instability‐high (MSI‐H) patients. Additionally, the guidelines offer detailed screening recommendations for hereditary gastric cancer and an appendix listing drug treatment regimens for various stages of gastric cancer. The 2023 CSCO Clinical Guidelines for Gastric Cancer updates are based on both Chinese and international clinical research and expert consensus to enhance their applicability and relevance in clinical practice, particularly in the heterogeneous healthcare landscape of China, while maintaining a commitment to scientific rigor, impartiality, and timely revisions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Bang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61121-x · Cited by 7,302
Self-citationPerioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
Cunningham, D., Allum, W. H., Stenning, S. P., Thompson, J. N., Van de Velde, C. J. H., Nicolson, M., Scarffe, J. H., Lofts, F. J., Falk, S. J., Iveson, T. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055531 · Cited by 6,334
LAURÉN, P. (1965) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/apm.1965.64.1.31 · Cited by 6,133
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
van Hagen, P., Hulshof, M. C. C. M., van Lanschot, J. J. B., Steyerberg, E. W., Henegouwen, M. I. V. B., Wijnhoven, B. P. L., Richel, D. J., Nieuwenhuijzen, G. A. P., Hospers, G. A. P., Bonenkamp, J. J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112088 · Cited by 5,521
Smyth, E. C., Nilsson, M., Grabsch, H. I., van Grieken, N. C., & Lordick, F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31288-5 · Cited by 4,803
The 2019 WHO classification of tumours of the digestive system
Nagtegaal, I. D., Odze, R. D., Klimstra, D., Paradis, V., Rugge, M., Schirmacher, P., Washington, K. M., Carneiro, F., Cree, I. A., & the WHO Classification of Tumours Editorial Board (2020) · Histopathology · doi:10.1111/his.13975 · Cited by 4,192
Macdonald, J. S., Smalley, S. R., Benedetti, J., Hundahl, S. A., Estes, N. C., Stemmermann, G. N., Haller, D. G., Ajani, J. A., Gunderson, L. L., Jessup, J. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010187 · Cited by 3,475
Japanese classification of gastric carcinoma: 3rd English edition
Japanese Gastric Cancer Association (2011) · Gastric Cancer · doi:10.1007/s10120-011-0041-5 · Cited by 3,455
KONDRUP, J. (2003) · Clinical Nutrition · doi:10.1016/s0261-5614(02)00214-5 · Cited by 3,063
Janjigian, Y. Y., Shitara, K., Moehler, M., Garrido, M., Salman, P., Shen, L., Wyrwicz, L., Yamaguchi, K., Skoczylas, T., Campos Bragagnoli, A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00797-2 · Cited by 3,041
Self-citationAl-Batran, S.-E., Homann, N., Pauligk, C., Goetze, T. O., Meiler, J., Kasper, S., Kopp, H.-G., Mayer, F., Haag, G. M., Luley, K., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32557-1 · Cited by 2,648
Shapiro, J., van Lanschot, J. J. B., Hulshof, M. C. C. M., van Hagen, P., van Berge Henegouwen, M. I., Wijnhoven, B. P. L., van Laarhoven, H. W. M., Nieuwenhuijzen, G. A. P., Hospers, G. A. P., Bonenkamp, J. J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00040-6 · Cited by 2,565
Hellman, S., & Weichselbaum, R. R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.8 · Cited by 2,562
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
Sakuramoto, S., Sasako, M., Yamaguchi, T., Kinoshita, T., Fujii, M., Nashimoto, A., Furukawa, H., Nakajima, T., Ohashi, Y., Imamura, H., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072252 · Cited by 2,517
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Seymour, L., Bogaerts, J., Perrone, A., Ford, R., Schwartz, L. H., Mandrekar, S., Lin, N. U., Litière, S., Dancey, J., Chen, A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30074-8 · Cited by 2,472 · cited 1×
“In regard to immunotherapy, treatment efficacy can be evaluated by referring to the immune RECIST (iRECIST) criteria [9]. h Small sample-sized studies have shown that volume measurement [10] and functional imaging parameters such as the apparent diffusion coefficient value of diffusion-weighted MRI…”
BackgroundWilke, H., Muro, K., Van Cutsem, E., Oh, S.-C., Bodoky, G., Shimada, Y., Hironaka, S., Sugimoto, N., Lipatov, O., Kim, T.-Y., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70420-6 · Cited by 2,438
Japanese gastric cancer treatment guidelines 2014 (ver. 4)
Japanese Gastric Cancer Association (2017) · Gastric Cancer · doi:10.1007/s10120-016-0622-4 · Cited by 2,429
Kang, Y.-K., Boku, N., Satoh, T., Ryu, M.-H., Chao, Y., Kato, K., Chung, H. C., Chen, J.-S., Muro, K., Kang, W. K., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31827-5 · Cited by 2,252
Fuchs, C. S., Tomasek, J., Yong, C. J., Dumitru, F., Passalacqua, R., Goswami, C., Safran, H., dos Santos, L. V., Aprile, G., Ferry, D. R., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61719-5 · Cited by 2,188
Ychou, M., Boige, V., Pignon, J.-P., Conroy, T., Bouché, O., Lebreton, G., Ducourtieux, M., Bedenne, L., Fabre, J.-M., Saint-Aubert, B., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.0597 · Cited by 2,086
Van Cutsem, E., Moiseyenko, V. M., Tjulandin, S., Majlis, A., Constenla, M., Boni, C., Rodrigues, A., Fodor, M., Chao, Y., Voznyi, E., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8429 · Cited by 1,926
Koizumi, W., Narahara, H., Hara, T., Takagane, A., Akiya, T., Takagi, M., Miyashita, K., Nishizaki, T., Kobayashi, O., Takiyama, W., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70035-4 · Cited by 1,847
Japanese gastric cancer treatment guidelines 2018 (5th edition)
Japanese Gastric Cancer Association (2021) · Gastric Cancer · doi:10.1007/s10120-020-01042-y · Cited by 1,749
Bang, Y.-J., Kim, Y.-W., Yang, H.-K., Chung, H. C., Park, Y.-K., Lee, K. H., Lee, K.-W., Kim, Y. H., Noh, S.-I., Cho, J. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61873-4 · Cited by 1,705
Self-citationGastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Ajani, J. A., D’Amico, T. A., Bentrem, D. J., Chao, J., Cooke, D., Corvera, C., Das, P., Enzinger, P. C., Enzler, T., Fanta, P., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0008 · Cited by 1,684
Syngal, S., Brand, R. E., Church, J. M., Giardiello, F. M., Hampel, H. L., & Burt, R. W. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.435 · Cited by 1,662
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Smyth, E. C., Verheij, M., Allum, W., Cunningham, D., Cervantes, A., & Arnold, D. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw350 · Cited by 1,555
Sasako, M., Sakuramoto, S., Katai, H., Kinoshita, T., Furukawa, H., Yamaguchi, T., Nashimoto, A., Fujii, M., Nakajima, T., & Ohashi, Y. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.5908 · Cited by 1,434
Tepper, J., Krasna, M. J., Niedzwiecki, D., Hollis, D., Reed, C. E., Goldberg, R., Kiel, K., Willett, C., Sugarbaker, D., & Mayer, R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.9593 · Cited by 1,352
Trastuzumab deruxtecan in previously treated HER2-positive gastric cancer
Shitara, K., Bang, Y.-J., Iwasa, S., Sugimoto, N., Ryu, M.-H., Sakai, D., Chung, H.-C., Kawakami, H., Yabusaki, H., Lee, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004413 · Cited by 1,333
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Okines, A., Verheij, M., Allum, W., Cunningham, D., & Cervantes, A. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq164 · Cited by 1,300
Shitara, K., Özgüroğlu, M., Bang, Y.-J., Di Bartolomeo, M., Mandalà, M., Ryu, M.-H., Fornaro, L., Olesiński, T., Caglevic, C., Chung, H. C., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31257-1 · Cited by 1,296
Fukase, K., Kato, M., Kikuchi, S., Inoue, K., Uemura, N., Okamoto, S., Terao, S., Amagai, K., Hayashi, S., & Asaka, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61159-9 · Cited by 1,244
Bauer, J., Capra, S., & Ferguson, M. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601412 · Cited by 1,178 · cited 1×
“The PG-SGA is a specific nutritionalassessmenttoolforquickidentificationofcancerpatientswithmalnutrition[266,269].”
Wagner, A. D., Grothe, W., Haerting, J., Kleber, G., Grothey, A., & Fleig, W. E. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.0245 · Cited by 1,171 · cited 1×
“…general condition, the irradiation target volume, expected lifespan, and possible irradiation damage to surrounding normal tissues and organs. g Compared to best supportive care, effective systemic therapy can prolong the survival of patients with advanced or metastatic gastric cancer [148].”
BackgroundShitara, K., Van Cutsem, E., Bang, Y.-J., Fuchs, C., Wyrwicz, L., Lee, K.-W., Kudaba, I., Garrido, M., Chung, H. C., Lee, J., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.3370 · Cited by 1,141
D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer
Sasako, M., Sano, T., Yamamoto, S., Kurokawa, Y., Nashimoto, A., Kurita, A., Hiratsuka, M., Tsujinaka, T., Kinoshita, T., Arai, K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707035 · Cited by 1,021
Li, J., Qin, S., Xu, J., Xiong, J., Wu, C., Bai, Y., Liu, W., Tong, J., Liu, Y., Xu, R., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.5995 · Cited by 972
Self-citationStahl, M., Walz, M. K., Stuschke, M., Lehmann, N., Meyer, H.-J., Riera-Knorrenschild, J., Langer, P., Engenhart-Cabillic, R., Bitzer, M., Königsrainer, A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0506 · Cited by 948
Lee, J., Lim, D. H., Kim, S., Park, S. H., Park, J. O., Park, Y. S., Lim, H. Y., Choi, M. G., Sohn, T. S., Noh, J. H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.1953 · Cited by 803
Kang, Y.-K., Chen, L.-T., Ryu, M.-H., Oh, D.-Y., Oh, S. C., Chung, H. C., Lee, K.-W., Omori, T., Shitara, K., Sakuramoto, S., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00692-6 · Cited by 800
Guidelines for the management of oesophageal and gastric cancer
Allum, W. H., Blazeby, J. M., Griffin, S. M., Cunningham, D., Jankowski, J. A., Wong, R., & On behalf of the Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, T. B. S. O. G. A. T. B. A. O. S. O. (2011) · Gut · doi:10.1136/gut.2010.228254 · Cited by 793
Al-Batran, S.-E., Hartmann, J. T., Probst, S., Schmalenberg, H., Hollerbach, S., Hofheinz, R., Rethwisch, V., Seipelt, G., Homann, N., Wilhelm, G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9378 · Cited by 782
Consensus guidelines for enhanced recovery after gastrectomy
Mortensen, K., Nilsson, M., Slim, K., Schäfer, M., Mariette, C., Braga, M., Carli, F., Demartines, N., Griffin, S. M., Lassen, K., et al. (2014) · British Journal of Surgery · doi:10.1002/bjs.9582 · Cited by 767
Kang, Y.-K., Kang, W.-K., Shin, D.-B., Chen, J., Xiong, J., Wang, J., Lichinitser, M., Guan, Z., Khasanov, R., Zheng, L., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn717 · Cited by 764
Lenz, H.-J., Van Cutsem, E., Luisa Limon, M., Wong, K. Y. M., Hendlisz, A., Aglietta, M., García-Alfonso, P., Neyns, B., Luppi, G., Cardin, D. B., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01015 · Cited by 728
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
Janjigian, Y. Y., Kawazoe, A., Yañez, P., Li, N., Lonardi, S., Kolesnik, O., Barajas, O., Bai, Y., Shen, L., Tang, Y., et al. (2021) · Nature · doi:10.1038/s41586-021-04161-3 · Cited by 720
Self-citationFujitani, K., Yang, H.-K., Mizusawa, J., Kim, Y.-W., Terashima, M., Han, S.-U., Iwasaki, Y., Hyung, W. J., Takagane, A., Park, D. J., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00553-7 · Cited by 712
Schuhmacher, C., Gretschel, S., Lordick, F., Reichardt, P., Hohenberger, W., Eisenberger, C. F., Haag, C., Mauer, M. E., Hasan, B., Welch, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.6114 · Cited by 709
Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond
Hansford, S., Kaurah, P., Li-Chang, H., Woo, M., Senz, J., Pinheiro, H., Schrader, K. A., Schaeffer, D. F., Shumansky, K., Zogopoulos, G., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2014.168 · Cited by 694
Yu, J., Huang, C., Sun, Y., Su, X., Cao, H., Hu, J., Wang, K., Suo, J., Tao, K., He, X., et al. (2019) · JAMA · doi:10.1001/jama.2019.5359 · Cited by 690
Self-citationSano, T., Sasako, M., Yamamoto, S., Nashimoto, A., Kurita, A., Hiratsuka, M., Tsujinaka, T., Kinoshita, T., Arai, K., Yamamura, Y., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.184 · Cited by 672
Endoscopic resection of early gastric cancer
Gotoda, T. (2007) · Gastric Cancer · doi:10.1007/s10120-006-0408-1 · Cited by 666
Satoh, T., Xu, R.-H., Chung, H. C., Sun, G.-P., Doi, T., Xu, J.-M., Tsuji, A., Omuro, Y., Li, J., Wang, J.-W., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.6136 · Cited by 624
Self-citationHecht, J. R., Bang, Y.-J., Qin, S. K., Chung, H. C., Xu, J. M., Park, J. O., Jeziorski, K., Shparyk, Y., Hoff, P. M., Sobrero, A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.6598 · Cited by 624
Self-citationMicrosatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer
Latham, A., Srinivasan, P., Kemel, Y., Shia, J., Bandlamudi, C., Mandelker, D., Middha, S., Hechtman, J., Zehir, A., Dubard-Gault, M., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.00283 · Cited by 616
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results
Qi, C., Gong, J., Li, J., Liu, D., Qin, Y., Ge, S., Zhang, M., Peng, Z., Zhou, J., Cao, Y., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01800-8 · Cited by 604
Self-citationvan der Post, R. S., Vogelaar, I. P., Carneiro, F., Guilford, P., Huntsman, D., Hoogerbrugge, N., Caldas, C., Chelcun Schreiber, K. E., Hardwick, R. H., Ausems, M. G. E. M., et al. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103094 · Cited by 561
Cats, A., Jansen, E. P. M., van Grieken, N. C. T., Sikorska, K., Lind, P., Nordsmark, M., Meershoek-Klein Kranenbarg, E., Boot, H., Trip, A. K., Swellengrebel, H. A. M., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30132-3 · Cited by 561
Hironaka, S., Ueda, S., Yasui, H., Nishina, T., Tsuda, M., Tsumura, T., Sugimoto, N., Shimodaira, H., Tokunaga, S., Moriwaki, T., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5805 · Cited by 541
Yamada, Y., Higuchi, K., Nishikawa, K., Gotoh, M., Fuse, N., Sugimoto, N., Nishina, T., Amagai, K., Chìn, K., Niwa, Y., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu472 · Cited by 536
Kim, H.-H., Han, S.-U., Kim, M.-C., Kim, W., Lee, H.-J., Ryu, S. W., Cho, G. S., Kim, C. Y., Yang, H.-K., Park, D. J., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.6727 · Cited by 512
Shitara, K., Doi, T., Dvorkin, M., Mansoor, W., Arkenau, H.-T., Prokharau, A., Alsina, M., Ghidini, M., Faustino, C., Gorbunova, V., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30739-3 · Cited by 511
Hereditary diffuse gastric cancer: updated clinical practice guidelines
Blair, V. R., McLeod, M., Carneiro, F., Coit, D. G., D'Addario, J. L., van Dieren, J. M., Harris, K. L., Hoogerbrugge, N., Oliveira, C., van der Post, R. S., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30219-9 · Cited by 491
Tabernero, J., Hoff, P. M., Shen, L., Ohtsu, A., Shah, M. A., Cheng, K., Song, C., Wu, H., Eng-Wong, J., Kim, K., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30481-9 · Cited by 490
Self-citationPietrantonio, F., Miceli, R., Raimondi, A., Kim, Y. W., Kang, W. K., Langley, R. E., Choi, Y. Y., Kim, K.-M., Nankivell, M. G., Morano, F., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.01124 · Cited by 487
Sasako, M., Sano, T., Yamamoto, S., Sairenji, M., Arai, K., Kinoshita, T., Nashimoto, A., & Hiratsuka, M. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70766-5 · Cited by 440
Milano, M. T., Katz, A. W., Zhang, H., & Okunieff, P. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.08.036 · Cited by 439
Zhang, X., Liang, H., Li, Z., Xue, Y., Wang, Y., Zhou, Z., Yu, J., Bu, Z., Chen, L., Du, Y., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00297-7 · Cited by 437
Self-citationPark, S. H., Sohn, T. S., Lee, J., Lim, D. H., Hong, M. E., Kim, K.-M., Sohn, I., Jung, S. H., Choi, M. G., Lee, J. H., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.3930 · Cited by 427
Dong, D., Tang, L., Li, Z. Y., Fang, M. J., Gao, J. B., Shan, X. H., Ying, X. J., Sun, Y. S., Fu, J., Wang, X. X., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz001 · Cited by 416
Self-citationAndré, T., Tougeron, D., Piessen, G., de la Fouchardière, C., Louvet, C., Adenis, A., Jary, M., Tournigand, C., Aparicio, T., Desrame, J., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.00686 · Cited by 414
Yoshida, K., Kodera, Y., Kochi, M., Ichikawa, W., Kakeji, Y., Sano, T., Nagao, N., Takahashi, M., Takagane, A., Watanabe, T., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01138 · Cited by 392
Ajani, J. A., Winter, K., Okawara, G. S., Donohue, J. H., Pisters, P. W. T., Crane, C. H., Greskovich, J. F., Anne, P. R., Bradley, J. D., Willett, C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4840 · Cited by 385
Janjigian, Y. Y., Maron, S. B., Chatila, W. K., Millang, B., Chavan, S. S., Alterman, C., Chou, J. F., Segal, M. F., Simmons, M. Z., Momtaz, P., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30169-8 · Cited by 362
Oligometastases and Oligo-recurrence: The New Era of Cancer Therapy
Niibe, Y., & Hayakawa, K. (2010) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp167 · Cited by 359
Kang, Y.-K., Yook, J. H., Park, Y.-K., Lee, J. S., Kim, Y.-W., Kim, J. Y., Ryu, M.-H., Rha, S. Y., Chung, I. J., Kim, I.-H., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.02914 · Cited by 359
Ishigami, H., Fujiwara, Y., Fukushima, R., Nashimoto, A., Yabusaki, H., Imano, M., Imamoto, H., Kodera, Y., Uenosono, Y., Amagai, K., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.77.8613 · Cited by 353
Yoshida, K., Yamaguchi, K., Okumura, N., Tanahashi, T., & Kodera, Y. (2016) · Gastric Cancer · doi:10.1007/s10120-015-0575-z · Cited by 350
Katai, H., Mizusawa, J., Katayama, H., Morita, S., Yamada, T., Bando, E., Ito, S., Takagi, M., Takagane, A., Teshima, S., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30332-2 · Cited by 330
Identification of germ-line E-cadherin mutations in gastric cancer families of European origin.
Gayther, S. A., Gorringe, K. L., Ramus, S. J., Huntsman, D. D., Roviello, G., Grehan, N., Machado, J. C., Pinto, E., Seruca, R., Halling, K. C., et al. (1998) · PubMed · Cited by 325
Dose-Escalation Study of Single-Fraction Stereotactic Body Radiotherapy for Liver Malignancies
Goodman, K. A., Wiegner, E. A., Maturen, K. E., Zhang, Z., Mo, Q., Yang, G., Gibbs, I. C., Fisher, G. A., & Koong, A. C. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.08.020 · Cited by 323
Sano, T., Sasako, M., Mizusawa, J., Yamamoto, S., Katai, H., Yoshikawa, T., Nashimoto, A., Ito, S., Kaji, M., Imamura, H., et al. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000001814 · Cited by 323
Hatta, W., Gotoda, T., Oyama, T., Kawata, N., Takahashi, A., Yoshifuku, Y., Hoteya, S., Nakagawa, M., Hirano, M., Esaki, M., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.95 · Cited by 321
Worthley, D. L., Phillips, K. D., Wayte, N., Schrader, K. A., Healey, S., Kaurah, P., Shulkes, A., Grimpen, F., Clouston, A., Moore, D., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300348 · Cited by 308
Ajani, J. A., Mansfield, P. F., Crane, C. H., Wu, T. T., Lunagomez, S., Lynch, P. M., Janjan, N., Feig, B., Faust, J., Yao, J. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.305 · Cited by 282
Lu, J., Zheng, C.-H., Xu, B.-B., Xie, J.-W., Wang, J.-B., Lin, J.-X., Chen, Q.-Y., Cao, L.-L., Lin, M., Tu, R.-H., et al. (2021) · Annals of Surgery · doi:10.1097/sla.0000000000004466 · Cited by 243
Liu, F., Huang, C., Xu, Z., Su, X., Zhao, G., Ye, J., Du, X., Huang, H., Hu, J., Li, G., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.3152 · Cited by 233
Self-citationPhase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer
Yoshikawa, T., Sasako, M., Yamamoto, S., Sano, T., Imamura, H., Fujitani, K., Oshita, H., Ito, S., Kawashima, Y., & Fukushima, N. (2009) · British Journal of Surgery · doi:10.1002/bjs.6665 · Cited by 231
Risk and Epidemiological Time Trends of Gastric Cancer in Lynch Syndrome Carriers in The Netherlands
Capelle, L. G., Van Grieken, N. C. T., Lingsma, H. F., Steyerberg, E. W., Klokman, W. J., Bruno, M. J., Vasen, H. F. A., & Kuipers, E. J. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.10.051 · Cited by 230
Moehler, M., Dvorkin, M., Boku, N., Özgüroğlu, M., Ryu, M.-H., Muntean, A. S., Lonardi, S., Nechaeva, M., Bragagnoli, A. C., Coşkun, H. S., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.00892 · Cited by 229
An α‐E‐catenin (CTNNA1) mutation in hereditary diffuse gastric cancer
Majewski, I. J., Kluijt, I., Cats, A., Scerri, T. S., de Jong, D., Kluin, R. J., Hansford, S., Hogervorst, F. B., Bosma, A. J., Hofland, I., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4152 · Cited by 222
Shitara, K., Takashima, A., Fujitani, K., Koeda, K., Hara, H., Nakayama, N., Hironaka, S., Nishikawa, K., Makari, Y., Amagai, K., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30219-9 · Cited by 217
Mocellin, S., & Pasquali, S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009944.pub2 · Cited by 215
Peng, Z., Liu, T., Wei, J., Wang, A., He, Y., Yang, L., Zhang, X., Fan, N., Luo, S., Li, Z., et al. (2021) · Cancer Communications · doi:10.1002/cac2.12214 · Cited by 210
Self-citationGastrointestinal Endoscopy Group of Japan Clinical Oncology Group (JCOG-GIESG), Hasuike, N., Ono, H., Boku, N., Mizusawa, J., Takizawa, K., Fukuda, H., Oda, I., Doyama, H., Kaneko, K., et al. (2018) · Gastric Cancer · doi:10.1007/s10120-017-0704-y · Cited by 208
Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer
Wang, D.-S., Liu, Z.-X., Lu, Y.-X., Bao, H., Wu, X., Zeng, Z.-L., Liu, Z., Zhao, Q., He, C.-Y., Lu, J.-H., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316522 · Cited by 195
Self-citationHall, P. S., Swinson, D., Cairns, D. A., Waters, J. S., Petty, R., Allmark, C., Ruddock, S., Falk, S., Wadsley, J., Roy, R., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.0848 · Cited by 195
Self-citationOn behalf of the Stomach Cancer Study Group of Japan Clinical Oncology Group, Katai, H., Mizusawa, J., Katayama, H., Kunisaki, C., Sakuramoto, S., Inaki, N., Kinoshita, T., Iwasaki, Y., Misawa, K., et al. (2019) · Gastric Cancer · doi:10.1007/s10120-019-00929-9 · Cited by 188
Zhao, J. J., Yap, D. W. T., Chan, Y. H., Tan, B. K. J., Teo, C. B., Syn, N. L., Smyth, E. C., Soon, Y. Y., & Sundar, R. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01862 · Cited by 184
Li, Z., Shan, F., Ying, X., Zhang, Y., E, J.-Y., Wang, Y., Ren, H., Su, X., & Ji, J. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2019.3473 · Cited by 172
Self-citationJiang, Y., Jin, C., Yu, H., Wu, J., Chen, C., Yuan, Q., Huang, W., Hu, Y., Xu, Y., Zhou, Z., et al. (2021) · Annals of Surgery · doi:10.1097/sla.0000000000003778 · Cited by 169
Self-citationLeong, T., Smithers, B. M., Michael, M., Gebski, V., Boussioutas, A., Miller, D., Simes, J., Zalcberg, J., Haustermans, K., Lordick, F., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1529-x · Cited by 165
Li, J., Deng, Y., Zhang, W., Zhou, A., Guo, W., Yang, J., Yuan, Y., Zhu, L., Qin, S., Xiang, S., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01095-1 · Cited by 160
Self-citationGuo, Z., Yu, J. M., Li, W., Fu, Z., Lin, Y., Shi, Y., Hu, W., Ba, Y., Li, S. Y., Li, Z. N., et al. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04803-3 · Cited by 156
Self-citationSlagter, A. E., Jansen, E. P. M., van Laarhoven, H. W. M., van Sandick, J. W., van Grieken, N. C. T., Sikorska, K., Cats, A., Muller-Timmermans, P., Hulshof, M. C. C. M., Boot, H., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4770-2 · Cited by 151
Sumpter, K., Harper-Wynne, C. L., Cunningham, D., Rao, S., Tebbutt, N. C., Norman, A. R., Ward, C., Iveson, T. J., Nicolson, M. C., Hickish, T., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602572 · Cited by 147
Self-citationLu, Z., Fang, Y., Liu, C. X., Zhang, X., Xin, X., He, Y., Cao, Y., Jiao, X., Sun, T., Pang, Y. K., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01254 · Cited by 142
Self-citationSupportive care in cancer—a MASCC perspective
Olver, I., Keefe, D., Herrstedt, J., Warr, D. G., Roila, F., & Ripamonti, C. I. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05447-4 · Cited by 140
Ikoma, N., Blum, M. A., Chiang, Y., Estrella, J. S., Roy‐Chowdhuri, S., Fournier, K. F., Mansfield, P., Ajani, J. A., & Badgwell, B. D. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5409-7 · Cited by 137
Akagi, K., Oki, E., Taniguchi, H., Nakatani, K., Aoki, D., Kuwata, T., & Yoshino, T. (2021) · Cancer Science · doi:10.1111/cas.14798 · Cited by 137
Yamada, Y., Boku, N., Mizusawa, J., Iwasa, S., Kadowaki, S., Nakayama, N., Azuma, M., Sakamoto, T., Shitara, K., Tamura, T., et al. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30083-4 · Cited by 126
Leake, P., Cardoso, R., Seevaratnam, R., Lourenço, L. G., Helyer, L. K., Mahar, A. L., Rowsell, C. H., & Coburn, N. G. (2011) · Gastric Cancer · doi:10.1007/s10120-011-0071-z · Cited by 116
Khushalani, N. I., Leichman, C. G., Proulx, G. M., Nava, H., Bodnar, L. M., Klippenstein, D. L., Litwin, A. M., Smith, J. L., Nava, M. E. R., Pendyala, L., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.032 · Cited by 116
Xie, T., Liu, Y., Zhang, Z., Zhang, X., Gong, J., Qi, C., Li, J., Shen, L., & Peng, Z. (2020) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000316 · Cited by 112
Self-citationChoi, J. M., Kim, S. G., Choi, J., Park, J., Oh, S., Yang, H., Lim, J. H., Im, J. P., Kim, J. S., & Jung, H. C. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.05.009 · Cited by 111
Wang, J., Xu, R., Li, J., Bai, Y., Liu, T., Jiao, S., Dai, G., Xu, J., Liu, Y., Fan, N., et al. (2015) · Gastric Cancer · doi:10.1007/s10120-015-0457-4 · Cited by 108
Self-citationKim, Y. K., Lee, M. W., Lee, W. J., Kim, S. H., Rhim, H., Lim, J. H., Choi, D., Kim, Y., Jang, K. M., Lee, S. J., et al. (2012) · Investigative Radiology · doi:10.1097/rli.0b013e31823a1495 · Cited by 104
Xu, R.-H., Zhang, Y., Pan, H., Feng, J., Zhang, T., Liu, T., Qin, Y., Qin, S., Yin, X., Liu, B., et al. (2021) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(21)00313-7 · Cited by 98
Self-citationAl-Batran, S.-E., Lorenzen, S., Thuss-Patience, P. C., Homann, N., Schenk, M., Lindig, U., Heuer, V., Kretzschmar, A., Goekkurt, E., Haag, G. M., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.2022.40.16_suppl.4003 · Cited by 97
Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance
Kluijt, I., Sijmons, R. H., Hoogerbrugge, N., et al. (2012) · Familial Cancer · doi:10.1007/s10689-012-9521-y · Cited by 95
Pietrantonio, F., Raimondi, A., Lonardi, S., Murgioni, S., Cardellino, G. G., Tamberi, S., Strippoli, A., Palermo, F., Prisciandaro, M., Randon, G., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.2023.41.4_suppl.358 · Cited by 94
Bajetta, E., Floriani, I., Bartolomeo, M. D., Labianca, R., Falcone, A., Costanzo, F. D., Comella, G., Amadori, D., Pinto, C., Carlomagno, C., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu146 · Cited by 92
Tang, Z., Wang, Y., Liu, D., Wang, X., Xu, C., Yu, Y., Cui, Y., Tang, C. W., Li, Q., Sun, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34403-5 · Cited by 91
Self-citationKang, Y., Shah, M. A., Ohtsu, A., Cutsem, E. V., Ajani, J. A., van der Horst, T., Harle-Yge, M.-L., Piao, Y., Althaus, B., & Thuss-Patience, P. C. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.4_suppl.5 · Cited by 83
Zhu, M., Chen, C., Foster, N. R., Hartley, C., Mounajjed, T., Salomao, M. A., Fruth, B. F., Beamer, S. E., Kim, Y., Harrington, S. M., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0413 · Cited by 79
Shin, H.-J., Son, S., Wang, B., Roh, C. K., Hur, H., & Han, S. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003845 · Cited by 70
Qiu, M., Li, Q., Wang, Z., Liu, T.-S., Liu, Q., Wei, X., Jin, Y., Wang, D., Ren, C., Bai, L., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28559 · Cited by 67
Self-citationEto, K., Hiki, N., Kumagai, K., Shoji, Y., Tsuda, Y., Kano, Y., Yasufuku, I., Okumura, Y., Tsujiura, M., Ida, S., et al. (2017) · Gastric Cancer · doi:10.1007/s10120-017-0781-y · Cited by 62
Lü, Z., Zhang, X., Liu, W., Liu, T., Hu, B., Li, W., Fan, Q., Xu, J., Xu, N., Bai, Y., et al. (2018) · Gastric Cancer · doi:10.1007/s10120-018-0809-y · Cited by 59
Self-citationGiganti, F., COBELLI, F. D., Canevari, C., et al. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24464 · Cited by 58
Xie, T., Zhang, Z., Zhang, X., Qi, C., Shen, L., & Peng, Z. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.646355 · Cited by 54
Self-citationHwang, I. G., Ji, J. H., Kang, J. H., Lee, H. R., Lee, H.-Y., Chi, K., Park, S. W., Lee, S. J., Kim, S. T., Lee, J., et al. (2017) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2017.01.002 · Cited by 51
Self-citationHall, P. S., Lord, S., Collinson, M., Marshall, H. C., Jones, M., Lowe, C., Howard, H., Swinson, D., Velikova, G., Anthoney, A., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2016.442 · Cited by 48
Li, Q., Jiang, H., Li, H., Xu, R., Shen, L., Yu, Y., Wang, Y., Cui, Y., Li, W., Yu, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10456 · Cited by 47
Self-citationInoue, T., Yachida, S., Usuki, H., Kimura, T., Hagiike, M., Okano, K., & Suzuki, Y. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2332-4 · Cited by 44
Adjuvant Chemotherapy in Microsatellite Instability-High Gastric Cancer
Kim, J. W., Cho, S., Chae, J., Kim, J., Kim, T., Lee, K., Oh, D., Bang, Y., & Im, S. (2020) · Cancer Research and Treatment · doi:10.4143/crt.2020.313 · Cited by 34
Qin, S., Ji, J., Xu, R., Wang, W., Tang, Y. C., Bi, F., Li, J., Wang, K., Xu, J., Fan, Q., et al. (2021) · The Oncologist · doi:10.1002/onco.13826 · Cited by 33
Self-citationQiu, M., He, C., Yang, D., Zhou, D., Zhao, B., Wang, X., Yang, L., Lu, S., Wang, F., & Xu, R. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920937434 · Cited by 29
Self-citationWang, Y., Cheng, X., Cui, Y., Hou, J., Ji, Y., Sun, Y., Shen, Z., Liu, F., & Liu, T. (2018) · BMC Cancer · doi:10.1186/s12885-018-4615-z · Cited by 26
Self-citationXu, G., Zhang, W., Lv, Y., Zhang, B., Sun, Q., Ling, T., Zhang, X., Zhou, Z.-H., Wang, L., Huang, Q. M., et al. (2015) · Surgical Endoscopy · doi:10.1007/s00464-015-4534-x · Cited by 25
Self-citationBrieau, B., Auzolle, C., Pozet, A., Tougeron, D., Bouché, O., Soibinet, P., Coriat, R., Prieux, C., Lecomte, T., Goujon, G., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.12.012 · Cited by 25
Whole-Exome Sequencing Among Chinese Patients With Hereditary Diffuse Gastric Cancer
Liu, Z., Zhang, X., Zhao, Q., Chen, Y., Sheng, H., He, C., Sun, Y., Lai, M.-Y., Wu, M., Zuo, Z., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.45836 · Cited by 25
Self-citationLin, J., Lin, J.-P., Wang, Z., Li, P., Xie, J., Wang, J.-B., Lü, J., Chen, Q., Cao, L., Lin, M., et al. (2022) · JAMA Surgery · doi:10.1001/jamasurg.2022.5307 · Cited by 22
Qin, S., Li, J., Zhong, H., Jin, C., Chen, L., Yuan, X., Fan, Q., Chen, K., Cao, P., Xiao, J. A., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.2021.39.15_suppl.2566 · Cited by 13
Self-citationWei, J., Lu, X., Liu, Q., Fu, Y. S., Liu, S., Li, L., Liu, F., Fan, X., Yang, J., Yang, Y., et al. (2022) · Cancer Management and Research · doi:10.2147/cmar.s355687 · Cited by 13
Self-citationLi, J., Xu, Y., Zang, A., Gao, Y., Gao, Q., Zhang, Y., Wang, D., Xu, J., Yuan, Y., Jiang, H., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.2021.39.15_suppl.2569 · Cited by 12
Self-citationPotentially curable gastric adenocarcinoma treated without surgery
Kaya, D. M., Nogueras-Gonzáles, G. M., Harada, K., Amlashi, F. G., Thomas, I., Rogers, J. E., Bhutani, M. S., Lee, J. H., Weston, B. R., Minsky, B. D., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.04.012 · Cited by 11
Gavriilidis, P., Roberts, K. J., de’Angelis, N., & Sutcliffe, R. P. (2019) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3925 · Cited by 11
Validation of a nomogram for selecting patients for chemotherapy after D2 gastrectomy for cancer
Wang, Z.-X., Li, G.-X., Zhou, Z.-W., Huang, Z.-P., Wang, F., & Xu, R. (2017) · British journal of surgery · doi:10.1002/bjs.10550 · Cited by 10
Self-citationSimplified and more sensitive criteria for identifying individuals with pathogenic CDH1 variants
Lerner, B. A., Xicola, R. M., Rodriguez, N. J., et al. (2022) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2021-108169 · Cited by 9
Zhang, J., Cuiping, X., Xie, J. W., Liang, N., Wang, J., Qiao, L., Luo, H., & Zhang, J. (2014) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.151487 · Cited by 7
Self-citationQi, C., Liu, C., Gong, J., Li, J., Liu, D., Ge, S., Zhang, M., Peng, Z., Zhou, J., Zhang, X., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.2022.40.16_suppl.4017 · Cited by 7
Self-citation
Metadata
- Authors
- Wang, F., Zhang, X., Tang, L., Wu, Q., Cai, M., Li, Y., Qu, X., Qiu, H., Zhang, Y., Ying, J., Zhang, J., Sun, L., Lin, R., Wang, C., Liu, H., Qiu, M., Guan, W., Rao, S., Ji, J., Xin, Y., Sheng, W., Xu, H., Zhou, Z., Zhou, A., Jin, J., Yuan, X., Bi, F., Liu, T., Liang, H., Zhang, Y., Li, G., Liang, J., Liu, B., Shen, L., Li, J., & Xu, R.
- Venue
- Cancer Communications
- Published
- 2023-12-31
- Volume
- 44
- Issue
- 1
- Pages
- 127-172
- ISSN
- 1000-467X (ISSN-L)
- 2523-3548
- OpenAlex
- W4390469429
- Cited by
- 428
- References
- 155
- FWCI
- 61.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.